Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials

被引：0
|
作者：
Abel, M. K. [1 ]
Diaz, I. [2 ]
Levine, J. [3 ]
Pate, L. [3 ]
Viggiano, E. [3 ]
Melisko, M. [4 ]
Mukhtar, R. [2 ]
机构：
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[3] Lobular Breast Canc Assoc, Patient Advocacy, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Med Hematol & Oncol, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [21] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [22] Does participation in clinical trials influence on survival in patients with metastatic breast cancer?
    Kim, T-Y
    Sohn, J. H.
    Kim, S-B
    Yoon, J. H.
    Kim, G. M.
    Lee, K. H.
    Koh, S-J
    Park, Y. H.
    Lee, S. E.
    Chae, Y.
    Lee, K. S.
    Lee, K. E.
    Won, H. S.
    Kim, J. H.
    Jeong, J.
    Park, K. H.
    Cho, E. K.
    Im, Y-H
    Im, S-A
    Jung, K. H.
    CANCER RESEARCH, 2016, 76
  • [23] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [24] CLINICAL CRITERIA THAT EXCLUDE METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS FROM PARTICIPATING IN CLINICAL TRIALS: RETROSPECTIVE ANALYSES IN A COMMUNITY-BASED HOSPITAL
    Alonso-Jaudenes, Guillermo
    Garcia-Campelo, Rosario
    Sande, Laura
    Roldan, Ana
    Anton Aparicio, Luis
    Fernandez, Natalia
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1279 - S1279
  • [25] Efficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive Lobular Carcinoma: A Pooled Analysis from Three Clinical Trials
    Perez-Garcia, Jose
    Cortes, Javier
    Metzger Filho, Otto
    ONCOLOGIST, 2019, 24 (08): : 1041 - 1047
  • [26] Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
    Heng, D. Y. C.
    Choueiri, T. K.
    Rini, B. I.
    Lee, J.
    Yuasa, T.
    Pal, S. K.
    Srinivas, S.
    Bjarnason, G. A.
    Knox, J. J.
    MacKenzie, M.
    Vaishampayan, U. N.
    Tan, M. H.
    Rha, S. Y.
    Donskov, F.
    Agarwal, N.
    Kollmannsberger, C.
    North, S.
    Wood, L. A.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 149 - 154
  • [27] Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
    De Schepper, Maxim
    Koorman, Thijs
    Richard, Francois
    Christgen, Matthias
    Vincent-Salomon, Anne
    Schnitt, Stuart J.
    van Diest, Paul J.
    Zels, Gitte
    Mertens, Freya
    Maetens, Marion
    Vanden Bempt, Isabelle
    Harbeck, Nadia
    Nitz, Ulrike
    Graser, Monika
    Kuemmel, Sherko
    Gluz, Oleg
    Weynand, Birgit
    Floris, Giuseppe
    Derksen, Patrick W. B.
    Desmedt, Christine
    MODERN PATHOLOGY, 2024, 37 (07)
  • [28] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Szlezinger, Katarzyna
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Klosowska, Danuta
    Gorski, Andrzej
    Borysowski, Jan
    BMC MEDICINE, 2023, 21 (01)
  • [29] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Katarzyna Szlezinger
    Katarzyna Pogoda
    Agnieszka Jagiełło-Gruszfeld
    Danuta Kłosowska
    Andrzej Górski
    Jan Borysowski
    BMC Medicine, 21
  • [30] Patients' Perceptions On Breast Cancer Clinical Trials
    Pittens, C. A. C. M.
    Elberse, J. E.
    Tax, S.
    van Leeuwen-Stok, A. E.
    Schrieks, M.
    Jonker, M.
    Broerse, J. E. W.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S50 - S50
12345